Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



STUELPNAGEL JOHN R Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Granted 1,865 shares @ $0
Granted 4,661 options to buy @ $57.62, valued at $268.6k
06/07/2023 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 10,000 shares @ $54.8894, valued at $548.9k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2022 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 3,218 shares @ $150.5596, valued at $484.5k
Sold 1,782 shares @ $151.565, valued at $270.1k
12/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2021 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 800 shares @ $157.5481, valued at $126k
Sold 3,052 shares @ $158.7888, valued at $484.6k
Sold 1,048 shares @ $159.8019, valued at $167.5k
Sold 100 shares @ $160.32, valued at $16k
11/03/2021 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 100 shares @ $160.33, valued at $16k
Sold 100 shares @ $160.75, valued at $16.1k
Sold 100 shares @ $161.52, valued at $16.2k
Sold 1,494 shares @ $163.0985, valued at $243.7k
Sold 2,906 shares @ $163.8899, valued at $476.3k
Sold 300 shares @ $164.58, valued at $49.4k
10/20/2021 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 4,400 shares @ $150.5136, valued at $662.3k
Sold 300 shares @ $151.4133, valued at $45.4k
Sold 300 shares @ $152.1968, valued at $45.7k
10/12/2021 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 5,000 shares @ $150.1798, valued at $750.9k
09/20/2021 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 700 shares @ $154.4529, valued at $108.1k
Sold 1,500 shares @ $155.689, valued at $233.5k
Sold 1,631 shares @ $156.7217, valued at $255.6k
Sold 1,169 shares @ $157.7455, valued at $184.4k
09/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2021 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 1,100 shares @ $178.4759, valued at $196.3k
Sold 1,140 shares @ $179.5341, valued at $204.7k
Sold 960 shares @ $180.3281, valued at $173.1k
Sold 1,100 shares @ $181.4724, valued at $199.6k
Sold 400 shares @ $182.74, valued at $73.1k
Sold 200 shares @ $183.9, valued at $36.8k
Sold 100 shares @ $184.99, valued at $18.5k
07/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2021 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 1,600 shares @ $189.943, valued at $303.9k
Sold 1,300 shares @ $190.8669, valued at $248.1k
Sold 700 shares @ $191.9734, valued at $134.4k
Sold 700 shares @ $193.5064, valued at $135.5k
Sold 500 shares @ $194.2869, valued at $97.1k
Sold 200 shares @ $196, valued at $39.2k
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/21/2021 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 1,400 shares @ $175.7879, valued at $246.1k
Sold 900 shares @ $176.5667, valued at $158.9k
Sold 1,110 shares @ $178.3111, valued at $197.9k
Sold 1,608 shares @ $179.2819, valued at $288.3k
Sold 1,206 shares @ $180.2707, valued at $217.4k
Sold 900 shares @ $181.4922, valued at $163.3k
Sold 376 shares @ $182.7821, valued at $68.7k
01/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/18/2020 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 1,101 shares @ $146.7815, valued at $161.6k
Sold 2,200 shares @ $147.6839, valued at $324.9k
Sold 3,098 shares @ $148.5048, valued at $460.1k
Sold 801 shares @ $149.3548, valued at $119.6k
Sold 300 shares @ $151.2367, valued at $45.4k
12/03/2020 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 2,100 shares @ $150.1461, valued at $315.3k
Sold 3,500 shares @ $150.9887, valued at $528.5k
Sold 500 shares @ $151.676, valued at $75.8k
Sold 500 shares @ $152.88, valued at $76.4k
Sold 900 shares @ $153.5367, valued at $138.2k
11/19/2020 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 400 shares @ $133.175, valued at $53.3k
Sold 1,576 shares @ $135.4061, valued at $213.4k
Sold 4,424 shares @ $136.1946, valued at $602.5k
Sold 1,100 shares @ $136.9701, valued at $150.7k
11/04/2020 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 2,328 shares @ $135.6197, valued at $315.7k
Sold 3,900 shares @ $136.2297, valued at $531.3k
Sold 772 shares @ $137.473, valued at $106.1k
Sold 500 shares @ $139.034, valued at $69.5k
10/20/2020 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 4,499 shares @ $163.9869, valued at $737.8k
Sold 3,001 shares @ $164.6649, valued at $494.2k
10/05/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy